Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021)
Xeris Biopharma Holdings (XERS) posted Capital Expenditures of $131000.0 for Q4 2021, down 41.78% on a QoQ basis from $225000.0 in Q4 2020, and down 41.78% year-over-year from $225000.0 in Q4 2020.
Xeris Biopharma Holdings (XERS) Capital Expenditures (2020 - 2021) Analysis & Trends
Xeris Biopharma Holdings' Capital Expenditures history runs 2 years deep, the most recent figure standing at $131000.0 for Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Xeris Biopharma Holdings | 1.43 Bn | 1.32 Bn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 131,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Dec 31, 2020 | 225,000.00 |
| Dec 31, 2020 | 225,000.00 |